Imagin Medical Overview
- Year Founded
-
1987
- Status
-
Public
- Stock Symbol
-
IME
- Investments
-
2
- Share Price
-
$0.01
- (As of Friday Closing)
Imagin Medical General Information
Description
Imagin Medical Inc is a surgical imaging company focused on developing technology to visualize cancer during minimally invasive procedures. Its initial focus is bladder cancer. Imagin's first product, the i/Blue Imaging System, is based on optics and light sensors and employs patented ultrasensitive imaging technology. The company believes the system, currently in the manufacturing stage, will significantly improve surgeon's ability to visualize and remove cancer cells. Run by a Boston-based management team, the company will work to enhance its market potential in the future by expanding its technology to multiple endoscopic procedures, such as laparoscopic and thoracic procedures, accommodating multiple contrast agents and illumination sources.
Contact Information
Website
www.imaginmedical.comCorporate Office
- 890 West Pender Street
- Suite 600
- Vancouver, British Columbia V6C 1J9
- Canada
Corporate Office
- 890 West Pender Street
- Suite 600
- Vancouver, British Columbia V6C 1J9
- Canada
Imagin Medical Stock Performance
As of 02-Feb-2024, Imagin Medical’s stock price is $0.01. Its current market cap is $121K with 10.8M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.01 | $0.01 | $121K | 10.8M | 21K | -$0.06 |
Imagin Medical Financials Summary
As of 31-Mar-2023, Imagin Medical has a trailing 12-month revenue of null.
|
In Thousands, USD |
TTM 31-Mar-2023 | FY 2022 30-Sep-2022 | FY 2021 30-Sep-2021 | FY 2020 30-Sep-2020 |
|---|---|---|---|---|
| EV | 11,566 | 9,126 | 4,139 | 3,134 |
| Revenue | 0 | 0 | 0 | 0 |
| EBITDA | (564) | (1,907) | (9,041) | (3,232) |
| Net Income | (664) | (1,950) | (9,069) | (3,252) |
| Total Assets | 844 | 988 | 607 | 164 |
| Total Debt | 10,018 | 9,839 | 9,189 | 0 |
Imagin Medical Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Imagin Medical Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Imagin Medical Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Imagin Medical Investments & Acquisitions (2)
Imagin Medical’s most recent deal was a Corporate Asset Purchase with Trod Medical (enCAGE Coil Precision Ablation System) for . The deal was made on 22-Aug-2022.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Trod Medical (enCAGE Coil Precision Ablation System) | 22-Aug-2022 | Corporate Asset Purchase | Therapeutic Devices | ||
| Expedition Mining | 10-Feb-2016 | Merger/Acquisition | Energy Exploration |
Imagin Medical FAQs
-
When was Imagin Medical founded?
Imagin Medical was founded in 1987.
-
Where is Imagin Medical headquartered?
Imagin Medical is headquartered in Vancouver, Canada.
-
What industry is Imagin Medical in?
Imagin Medical’s primary industry is Therapeutic Devices.
-
Is Imagin Medical a private or public company?
Imagin Medical is a Public company.
-
What is Imagin Medical’s stock symbol?
The ticker symbol for Imagin Medical is IME.
-
What is the current stock price of Imagin Medical?
As of 02-Feb-2024 the stock price of Imagin Medical is $0.01.
-
What is the current market cap of Imagin Medical?
The current market capitalization of Imagin Medical is $121K.
-
What is Imagin Medical’s annual earnings per share (EPS)?
Imagin Medical’s EPS for 12 months was -$0.06.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
